Want to join the conversation?
$ANGO's 4Q16 net sales rose 3% to $93.4MM versus $90.9MM in 4Q15. Peripheral Vascular net sales rose 10%, Vascular Access net sales fell 8.3% and Oncology/Surgery net sales were flat in the quarter. US net sales rose 4.2% and International net sales fell 2% versus 4Q15.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.